Discover
WST
West Pharmaceutical Services, Inc.
365.14
1 x 363.52
1 x 365.51
bid
ask
+
0.14
0.04%
11:26 AM
timesize
| Ytd | 32.71% | |
| 1y | 65.06% |
363.86
day range
367.57
206.80
52 week range
367.57
| Open | 366.08 | Prev Close | 365.00 | Low | 363.86 | High | 367.57 | Mkt Cap | 25.79B |
| Vol | 93.98K | Avg Vol | 855.04K | EPS | 7.48 | P/E | 48.81 | Forward P/E | 37.49 |
| Beta | 1.18 | Short Ratio | 3.43 | Inst. Own | 103.94% | Dividend | 0.88 | Div Yield | 0.25 |
| Ex Div Date | 04-29 | Earning | 07-23 | 50-d Avg | 317.99 | 200-d Avg | 275.44 | 1yr Est | 358.79 |
| Income Statement | |||
| Total Revenue | 844.90M | ||
| Revenues (USD) | 844.90M | ||
| Cost of Revenue | 548.50M | ||
| Gross Profit | 296.40M | ||
| Operating Expenses | 119.30M | ||
| Research and Development Expense | 15.80M | ||
| Selling, General and Administrative Expense | 99.50M | ||
| Operating Income | 177.10M | ||
| Interest Expense | 1.90M | ||
| Income Tax Expense | 44.70M | ||
| Net Income | 138.80M | ||
| Net Income Common Stock | 138.80M | ||
| Net Income Common Stock (USD) | 138.80M | ||
| Consolidated Income | 138.80M | ||
| Earnings per Basic Share | 1.93 | ||
| Earnings per Basic Share (USD) | 1.93 | ||
| Earnings per Diluted Share | 1.92 | ||
| Dividends per Basic Common Share | 0.22 | ||
| Earning Before Interest & Taxes (EBIT) | 185.40M | ||
| Earning Before Interest & Taxes (USD) | 185.40M | ||
| Weighted Average Shares | 72.00M | ||
| Weighted Average Shares Diluted | 72.40M | ||
| Balance Sheet | |||
| Cash and Equivalents | 521.40M | ||
| Cash and Equivalents (USD) | 521.40M | ||
| Investments | 209.20M | ||
| Investments Non-Current | 209.20M | ||
| Trade and Non-Trade Receivables | 685.60M | ||
| Current Assets | 1.83B | ||
| Property, Plant & Equipment Net | 1.81B | ||
| Total Assets | 4.11B | ||
| Debt Current | 21.40M | ||
| Total Debt | 316.20M | ||
| Current Liabilities | 674.00M | ||
| Debt Non-Current | 294.80M | ||
| Total Liabilities | 1.12B | ||
| Accumulated Retained Earnings (Deficit) | 4.48B | ||
| Accumulated Other Comprehensive Income | -125.20M | ||
| Shareholders Equity | 2.99B | ||
| Shareholders Equity (USD) | 2.99B | ||
| Assets Non-Current | 2.28B | ||
| Total Debt (USD) | 316.20M | ||
| Goodwill and Intangible Assets | 116.20M | ||
| Inventory | 452.60M | ||
| Liabilities Non-Current | 445.40M | ||
| Trade and Non-Trade Payables | 252.30M | ||
| Tax Assets | 63.90M | ||
| Tax Liabilities | 101.60M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 45.20M | ||
| Net Cash Flow from Financing | -308.70M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -269.90M | ||
| Capital Expenditure | -42.70M | ||
| Issuance (Purchase) of Equity Shares | -294.60M | ||
| Issuance (Repayment) of Debt Securities | -300.00K | ||
| Payment of Dividends & Other Cash Distributions | -15.80M | ||
| Net Cash Flow from Investing | -42.70M | ||
| Net Cash Flow from Operations | 89.90M | ||
| Effect of Exchange Rate Changes on Cash | -8.40M | ||
| Share Based Compensation | 6.60M | ||